NOV 17, 2015 1:53 PM PST

Experimental Alzheimer's Drug Has Anti-Aging Effect

WRITTEN BY: Julianne Chiaet
If given the choice, many of us would choose to stay young forever. Now, researchers at Salk Institute have found that drug candidate J147 has a host of unexpected anti-aging effects. The paper was published in the November 2015 edition of the journal Aging. 
 
Antonio Currais and David Schubert

The purpose of the J147 is to combat Alzheimer’s disease. About 3.8 million Americans currently experience symptoms of dementia, and Alzheimer’s disease accounts for 60 to 70 percent of those cases. Yet, despite the prevalence of the disease, the exact cause remains a mystery and there is no cure. The most a drug can do is slow the progression of the disease. 

One of the two major hallmarks of Alzheimer’s is the presence of amyloid plaque deposits in the brain. Alzheimer’s causes certain proteins, produced normally by the body, to abnormally divide. This, in turn, causes the presence of amyloid plaques. These plaques accumulate outside neurons and destroy them. "Most of the drugs developed in the past 20 years target the amyloid plaque deposits in the brain,” said David Schubert, senior author of the paper.

The researchers decided to tackle the problem from another angle. Certain aspects of old age may be the primary cause of Alzheimer’s. Thus, the Salk team synthesized J147 using cell-based screens against old age-associated brain toxins. They first published research on the drug in late 2011. The researchers found it improved memory and prevented brain damage caused by Alzheimer’s in mice that had the inherited form of the disease, the most commonly used mouse model in Alzheimer’s research. However, this form of Alzheimer’s only makes up one percent of all Alzheimer’s patients. 


In their new study, they expanded on their previous research. They wanted to explore the effects of J147 “in a novel animal model more similar to 99 percent of Alzheimer’s cases,” said lead study author Antonio Currais. The researchers used mice that more closely resemble the age-related common human disorder. Specifically, they age rapidly and experience age-related dementia. The team used three groups of the rapidly aging mice: a young group, an old group, and an old group that was fed J147 as it aged. 

They found that the old mice that were given J147 had improved memory, cognition, and motor movements. It restored synaptic function and even damaged blood vessels, which are a common feature of aging but much worse in Alzheimer’s disease. The mice treated with J147 also experienced reduced inflammation and reduced levels of oxidized fatty acids in the brain. 

"We did not predict we'd see this sort of anti-aging effect, but J147 made old mice look like they were young, based upon a number of physiological parameters,” said Currais.

The results are promising developments in treating both symptoms of Alzheimer’s and aging. The team hopes to begin human trials next year. 

Source: Salk Institute of Biological Studies

 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
JAN 30, 2020
Microbiology
JAN 30, 2020
25% of Antibiotic-Resistant Bacteria Can Spread Resistance Directly to Other Microbes
This research also suggests that antibiotics do not increase the rate at which bacteria acquire drug resistance genes....
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 14, 2020
Microbiology
FEB 14, 2020
Beneath the Surface, We All Carry the Same Microbes in Our Skin
Our skin is a critical barrier, and it is made up of three layers. It also carries a community of microbes - a skin microbiome....
FEB 16, 2020
Microbiology
FEB 16, 2020
Images of Coronavirus Are Released as First Death Outside China is Reported
Previously known as 2019-nCoV, the virus has a new name: SARS-CoV-2, which is the cause of what's being called COVID-19 disease....
FEB 18, 2020
Microbiology
FEB 18, 2020
Coronavirus Illness COVID-19 Has Now Caused Over 2,000 Deaths
The outbreak of COVID-19 disease caused by a novel coronavirus called SARS-CoV-2 has now claimed 2,005 lives and caused at least 75,079 cases....
Loading Comments...